END-VOC’s Legacy
As END-VOC comes to an end, this table summarises the [...]
Being Infected or Vaccinated First Influences COVID-19 Immunity
Using data from a healthcare worker cohort, ENDVOC researchers show [...]
The Sequence of Previous Diseases May Help Predict the Risk of Long COVID
A study by ENDVOC researchers using the COVICAT cohort identifies [...]
END-VOC Issues Strategic Recommendations to Strengthen Cohort-Based Research for Future Health Threats
The recommendations call on researchers, authorities and funders to ensure [...]
The END-VOC Consortium Holds its Final General Assembly Meeting in Lisbon
Project partners showcased major achievements and ongoing work including data [...]
The ENDVOC Consortium Calls for Funding, Research and Awareness on Long Covid and Other Post-Acute Infection Syndromes
A recently published document provides a timely update on the [...]
ENDVOC Study Finds Stronger Immune Response to SARS-CoV-2 Infection in People with Long COVID
The study, based on a population cohort in England, measured [...]
COVID-19 Vaccination Induces Long-Lasting Antibody B-cell Responses
END-VOC researchers followed a cohort of healthcare workers in Catalonia [...]
A Switch to IgG4 Antibodies After COVID-19 Vaccination May Increase the Risk of Breakthrough Infections
For over three years, ENDVOC researchers analysed the quantity and [...]
Symptoms of Long-COVID Can Last Up to Two Years After Infection, Say END-VOC Researchers
Almost one in four people infected with SARS-CoV-2 suffered from [...]
